BR112015015250A2 - derivados de pirrolidina, composições farmacêuticas e usos dos mesmos - Google Patents

derivados de pirrolidina, composições farmacêuticas e usos dos mesmos

Info

Publication number
BR112015015250A2
BR112015015250A2 BR112015015250A BR112015015250A BR112015015250A2 BR 112015015250 A2 BR112015015250 A2 BR 112015015250A2 BR 112015015250 A BR112015015250 A BR 112015015250A BR 112015015250 A BR112015015250 A BR 112015015250A BR 112015015250 A2 BR112015015250 A2 BR 112015015250A2
Authority
BR
Brazil
Prior art keywords
pharmaceutical compositions
pyrrolidine derivatives
derivatives
pyrrolidine
medicaments
Prior art date
Application number
BR112015015250A
Other languages
English (en)
Inventor
Nosse Bernd
Juergen Roth Gerald
Fleck Martin
Heine Niklas
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of BR112015015250A2 publication Critical patent/BR112015015250A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Abstract

resumo patente de invenção: "derivados de pirrolidina, composições farmacêuticas e usos dos mesmos". a presente invenção refere-se a novos derivados de pirrolidina da fórmula (i), , a seu uso como medicamentos, a métodos para seu uso terapêutico e a composições farmacêuticas que os contêm.
BR112015015250A 2013-01-25 2014-01-20 derivados de pirrolidina, composições farmacêuticas e usos dos mesmos BR112015015250A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13152734 2013-01-25
PCT/EP2014/050981 WO2014114578A1 (en) 2013-01-25 2014-01-20 Pyrrolidine derivatives, pharmaceutical compositions and uses thereof

Publications (1)

Publication Number Publication Date
BR112015015250A2 true BR112015015250A2 (pt) 2017-07-11

Family

ID=47630189

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015015250A BR112015015250A2 (pt) 2013-01-25 2014-01-20 derivados de pirrolidina, composições farmacêuticas e usos dos mesmos

Country Status (7)

Country Link
US (1) US8877741B2 (pt)
EP (1) EP2948442B1 (pt)
JP (1) JP6047825B2 (pt)
AU (1) AU2014210013A1 (pt)
BR (1) BR112015015250A2 (pt)
IL (1) IL238851A0 (pt)
WO (1) WO2014114578A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10150728B2 (en) 2013-10-17 2018-12-11 Shionogi & Co., Ltd. Alkylene derivatives
WO2016201662A1 (en) * 2015-06-18 2016-12-22 Eli Lilly And Company Fluoropyridyl pyrazol compounds
WO2018095344A1 (en) * 2016-11-24 2018-05-31 Shanghai Meton Pharmaceutical Co., Ltd Isocitrate dehydrogenase (idh) inhibitor
US20220055992A1 (en) 2018-12-21 2022-02-24 Saltigo Gmbh Process for preparing 2-alkoxy-4-amino-5-methyl-pyridines and/or 2-alkoxy-4-alkylamino-5-methyl-pyridines

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997028128A1 (en) 1996-02-02 1997-08-07 Zeneca Limited Heterocyclic compounds useful as pharmaceutical agents
BRPI0907584A2 (pt) * 2008-02-22 2015-07-21 Irm Llc Composto e composições como moduladores de atividade de gpr119
WO2012090219A2 (en) * 2010-12-31 2012-07-05 Jubilant Biosys Ltd. Thiazole compounds useful as acetyl-coa carboxylase (acc) inhibitors
US8530460B2 (en) * 2011-12-19 2013-09-10 Boehringer Ingelheim International Gmbh Azetidine derivatives

Also Published As

Publication number Publication date
US8877741B2 (en) 2014-11-04
EP2948442A1 (en) 2015-12-02
EP2948442B1 (en) 2016-10-26
JP2016509598A (ja) 2016-03-31
JP6047825B2 (ja) 2016-12-21
WO2014114578A1 (en) 2014-07-31
US20140213568A1 (en) 2014-07-31
IL238851A0 (en) 2015-06-30
AU2014210013A1 (en) 2015-06-04

Similar Documents

Publication Publication Date Title
CY1118379T1 (el) Αναστολεις ιου ηπατιτιδας c
CU20160087A7 (es) Indazolcarboxamidas, procedimientos para su preparación, preparaciones farmacéuticas que las contienen
BR112018005497A2 (pt) compostos heterocíclicos e usos dos mesmos
BR112015022191A2 (pt) compostos heteroarila, seu uso e composição que os compreende
BR112015021983A2 (pt) compostos heterocíclicos e usos dos mesmos
BR112017002053A2 (pt) composto de acordo com a fórmula (i), composição farmacêutica, e usos de um composto
BR112015004205A2 (pt) sulfamoil-arilamidas e o uso das mesmas como medicamentos para o tratamento da hepatite b
BR112015028538A2 (pt) derivados de sulfamoiltiofenamida e o uso dos mesmos como medicamentos para o tratamento da hepatite b
BR112015020389A8 (pt) compostos carbazol úteis como inibidores de bromodomínio, seu uso, bem como composição e produto farmacêuticos compreendendo os mesmos
BR112015022096A8 (pt) compostos moduladores de canal de sódio, composição que os compreende e uso dos mesmos
BR112014032734A2 (pt) derivados de pirrolidina e seu uso como moduladores da série de reação de complemento
BR112015000578A2 (pt) moduladores da via do complemento e usos dos mesmos
BR112015026023A2 (pt) derivados de 2- aminopirido[4,3-d]pirimidin-5-ona e seu uso como inibidores de wee-1
BR112013000059A2 (pt) derivados de piperidina e seus usos para o tratamento de distúrbios metabólicos
BR112017004741A2 (pt) compostos e composições como inibidores da raf quinase
ECSP14013275A (es) Derivados de estra-1,3,5(10),16-tetraen-3-carboxamida, procedimientos para su preparación, preparados farmacéuticos que los contienen, así como su uso para la preparación de medicamentos
CR20150007A (es) Derivados de estra-1,3,5(10),16-tetraeno 3-sustituidos, metodos para su preparación, preparaciones farmacéuticas que los contienen, así como su uso para la preparación de medicamentos
BR112015019590A2 (pt) derivados de ácido betulínico modificado com c-3 alquila e alquenila úteis no tratamento de hiv
BR112015007647A2 (pt) derivados de quetamina
BR112016011170A8 (pt) derivados de heteroaril ácido butanoico, seus usos, combinação e composição farmacêutica
DOP2018000062A (es) Piridinona dicaboxamidas para uso como inhibidores de bromodominio
BR112015030315A2 (pt) derivado de 4-alquinilimidazol e medicamento compreendendo o mesmo como ingrediente ativo
BR112015022758A2 (pt) derivados de pirrolidina, composições farmacêuticas contendo os mesmos e seu uso em terapia
BR112014012459A2 (pt) 2h-indazóis como antagonistas do receptor de ep2
BR112018001035A2 (pt) compostos de fenoxiacetamidas aneladas, sal farmaceuticamente aceitável, seu método de síntese, combinação de medicamento e uso dos mesmos

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]